{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:52:20Z","timestamp":1790797940129,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00564","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:11:52Z","timestamp":1562890312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth"],"prefix":"10.3389","volume":"9","author":[{"given":"Sarah","family":"Di Somma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelina Antonella","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Maria","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Gigantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Indovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pentimalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S1470-2045(13)70257-2","article-title":"Asbestos is not just asbestos: an unrecognised health hazard","volume":"14","author":"Baumann","year":"2013","journal-title":"Lancet Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.21037\/jtd.2017.12.146","article-title":"Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved","volume":"10","author":"Marinaccio","year":"2018","journal-title":"J Thorac Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/10937404.2016.1195322","article-title":"Environmental risk of mesothelioma in the United States: an emerging concern-epidemiological issues","volume":"19","author":"Baumann","year":"2016","journal-title":"J Toxicol Environ Health B Crit Rev."},{"key":"B5","unstructured":"III Italian consensus conference on malignant mesothelioma of the pleura. epidemiology, public health and occupational medicine related issues32532\n            MagnaniC\n            BianchiC\n            ChelliniE\n            ConsonniD\n            FubiniB\n            GennaroV\n          Med Lav.1062015"},{"key":"B6","unstructured":"MarinaccioA\n            BinazziA\n            BonafedeM\n            BranchiC\n            BuganiM\n            CorfiatiM\n          Sesto Rapporto Renam: Collana Ricerche2018"},{"key":"B7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 world health organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ejcts\/ezx427","article-title":"Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma","volume":"53","author":"Nelson","year":"2018","journal-title":"Eur J Cardiothorac Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jare.2014.11.012","article-title":"Mesothelioma treatment: are we on target? a review","volume":"6","author":"Hiddinga","year":"2015","journal-title":"J Adv Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic viral therapy and the immune system: a double-edged sword against cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fonc.2017.00179","article-title":"Oncolytic viral therapy for mesothelioma","volume":"7","author":"Pease","year":"2017","journal-title":"Front Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fonc.2017.00195","article-title":"Oncolytic viruses-interaction of virus and tumor cells in the battle to eliminate cancer","volume":"7","author":"Howells","year":"2017","journal-title":"Front Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-3-319-67577-0_11","article-title":"Oncolytic virotherapy and the tumor microenvironment","volume":"1036","author":"Berkey","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-018-0102-y","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e955691","DOI":"10.4161\/21624011.2014.955691","article-title":"Consensus guidelines for the detection of immunogenic cell death","volume":"3","author":"Kepp","year":"2014","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1476-4598-12-103","article-title":"Oncolytic viruses as therapeutic cancer vaccines","volume":"12","author":"Bartlett","year":"2013","journal-title":"Mol Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/cdd.2013.84","article-title":"Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments","volume":"21","author":"Inoue","year":"2014","journal-title":"Cell Death Differ."},{"key":"B19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/hum.2005.16.765","article-title":"Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma","volume":"16","author":"Benencia","year":"2005","journal-title":"Hum Gene Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/gt.2011.205","article-title":"Measles virus causes immunogenic cell death in human melanoma","volume":"20","author":"Donnelly","year":"2013","journal-title":"Gene Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1126\/science.1653969","article-title":"Cell cycle regulation of histone H1 kinase activity associated with the adenoviral protein E1A","volume":"253","author":"Giordano","year":"1991","journal-title":"Science."},{"key":"B22","first-page":"481","article-title":"Human cyclin a and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product","volume":"6","author":"Giordano","year":"1991","journal-title":"Oncogene."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat Med."},{"key":"B24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-812724-7.00009-5","article-title":"Molecular markers of mesothelioma aiding in diagnostic challenges: the combined use of p16 and BAP1","volume-title":"Malignant Pleural Mesothelioma: A Guide for Clinicians","author":"Forte","year":"2019"},{"key":"B25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/cgt.2011.45","article-title":"An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine","volume":"18","author":"Bhattacharyya","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/0008-5472.CAN-05-2691","article-title":"Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin","volume":"66","author":"Lockley","year":"2006","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/hum.2009.181","article-title":"PED\/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells","volume":"21","author":"Botta","year":"2010","journal-title":"Hum Gene Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1158\/1078-0432.CCR-08-0200","article-title":"Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947","volume":"14","author":"Libertini","year":"2008","journal-title":"Clin Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.18632\/oncotarget.6430","article-title":"The oncolytic virus dl922-947 reduces IL-8\/CXCL8 and MCP-1\/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma","volume":"7","author":"Passaro","year":"2016","journal-title":"Oncotarget."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1210\/en.2007-0752","article-title":"Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells","volume":"148","author":"Libertini","year":"2007","journal-title":"Endocrinology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1183\/09031936.00081310","article-title":"A 5-aza-2\u2032-deoxycytidine\/valproate combination induces cytotoxic T-cell response against mesothelioma","volume":"38","author":"Leclercq","year":"2011","journal-title":"Eur Respir J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4161\/cc.27546","article-title":"Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma","volume":"13","author":"Di Marzo","year":"2014","journal-title":"Cell Cycle."},{"key":"B33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jgm.1486","article-title":"Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus","volume":"12","author":"Kubo","year":"2010","journal-title":"J Gene Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/JTO.0b013e3182725fa4","article-title":"E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents","volume":"7","author":"Yamanaka","year":"2012","journal-title":"J Thorac Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1677\/ERC-10-0234","article-title":"AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947","volume":"18","author":"Libertini","year":"2011","journal-title":"Endocr Relat Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/ERC-13-0001","article-title":"Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells","volume":"20","author":"Passaro","year":"2013","journal-title":"Endocr Relat Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1038\/s41419-017-0110-8","article-title":"RIPK3 promotes adenovirus type 5 activity","volume":"8","author":"Weigert","year":"2017","journal-title":"Cell Death Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-018-0218-0","article-title":"Death and fire-the concept of necroinflammation","volume":"26","author":"Linkermann","year":"2019","journal-title":"Cell Death Differ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/JTO.0b013e3181d2f008","article-title":"Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma","volume":"5","author":"Yasumitsu","year":"2010","journal-title":"J Thorac Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jprot.2018.09.018","article-title":"Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma","volume":"192","author":"White","year":"2019","journal-title":"J Proteomics."},{"key":"B41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1517\/14728222.2012.712962","article-title":"Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets","volume":"16","author":"Hallden","year":"2012","journal-title":"Expert Opin Ther Targets."},{"key":"B42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.08.011","article-title":"The resistance related to targeted therapy in malignant pleural mesothelioma: why has not the target been hit yet?","volume":"107","author":"Bronte","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fimmu.2017.00555","article-title":"Oncolytic immunotherapy: conceptual evolution, current strategies, and future perspectives","volume":"8","author":"Guo","year":"2017","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/ijc.30228","article-title":"Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5\/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model","volume":"139","author":"Kuryk","year":"2016","journal-title":"Int J Cancer."},{"key":"B45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40425-016-0121-5","article-title":"Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers","volume":"4","author":"Ranki","year":"2016","journal-title":"J Immunother Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/cas.12267","article-title":"Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma","volume":"104","author":"Takagi-Kimura","year":"2013","journal-title":"Cancer Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4049\/jimmunol.1701021","article-title":"Critical Interactions between Immunogenic cancer cell death, oncolytic viruses, and the immune system define the rational design of combination immunotherapies","volume":"200","author":"van Vloten","year":"2018","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-018-0052-x.","article-title":"Cell death pathologies: targeting death pathways and the immune system for cancer therapy","author":"Pentimalli","year":"2018","journal-title":"Genes Immun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2018.03.011","article-title":"Oncolytic viruses as antigen-agnostic cancer vaccines","volume":"33","author":"Russell","year":"2018","journal-title":"Cancer Cell."},{"key":"B50","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":"Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":"Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma","volume":"72","author":"Jube","year":"2012","journal-title":"Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-15-1130","article-title":"HMGB1 and Its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients","volume":"22","author":"Napolitano","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B53","first-page":"367","article-title":"Interleukin 8: an autocrine growth factor for malignant mesothelioma","volume":"59","author":"Galffy","year":"1999","journal-title":"Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0169-5002(99)90762-6","article-title":"Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model","volume":"11","author":"Galffy","year":"1999","journal-title":"Oncol Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: american society of clinical oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12985-017-0818-1","article-title":"A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression","volume":"14","author":"Cao","year":"2017","journal-title":"Virol J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cgt.2009.44","article-title":"Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination","volume":"17","author":"Takakura","year":"2010","journal-title":"Cancer Gene Ther."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:12:11Z","timestamp":1562890331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":57,"alternative-id":["10.3389\/fonc.2019.00564"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00564","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"article-number":"564"}}